Upregulated SLC1A5 promotes cell growth and survival in colorectal cancer

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 9, 2014, Pages 6006-6014

  Huang, Fang ^a   Zhao, Yingchao ^a   Zhao, Junzhang ^a   Wu, Shuang ^a   Jiang, Yao ^a   Ma, Hong ^a   Zhang, Tao ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Colorectal cancer; SLC1A5; Therapeutic target; Tumorigenesis

Indexed keywords

AMINO ACID TRANSPORTER; SLC1A5 PROTEIN, HUMAN; TUMOR MARKER;

ADENOCARCINOMA; AGED; APOPTOSIS; CANCER STAGING; CELL PROLIFERATION; CELL SURVIVAL; COLLOID CARCINOMA; COLORECTAL TUMOR; FEMALE; GENETIC TRANSFECTION; GENETICS; HCT116 CELL LINE; HT 29 CELL LINE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; UPREGULATION;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; AGED; AMINO ACID TRANSPORT SYSTEM ASC; APOPTOSIS; BIOMARKERS, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL NEOPLASMS; FEMALE; HCT116 CELLS; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS; TRANSFECTION; UP-REGULATION;

EID: 84911945895     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hohla F, Winder T, Greil R, Rick FG, Block NL and Schally AV. Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectives. World J Gastroenterol 2014; 20: 6102-6112.
2. Hanahan D and Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
3. Hensley CT, Wasti AT and DeBerardinis RJ. Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest 2013; 123: 3678-3684.
4. Yuneva MO, Fan TW, Allen TD, Higashi RM, Ferraris DV, Tsukamoto T, Mates JM, Alonso FJ, Wang C, Seo Y, Chen X and Bishop JM. The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab 2012; 15: 157-170.
5. Wang JB, Erickson JW, Fuji R, Ramachandran S, Gao P, Dinavahi R, Wilson KF, Ambrosio AL, Dias SM, Dang CV and Cerione RA. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 2010; 18: 207-219.
6. Huang F, Zhang Q, Ma H, Lv Q and Zhang T. Expression of glutaminase is upregulated in colorectal cancer and of clinical significance. Int J Clin Exp Pathol 2014; 7: 1093-1100.
7. Hassanein M, Hoeksema MD, Shiota M, Qian J, Harris BK, Chen H, Clark JE, Alborn WE, Eisenberg R and Massion PP. SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival. Clin Cancer Res 2013; 19: 560-570.
8. Wang Q, Beaumont KA, Otte NJ, Font J, Bailey CG, van Geldermalsen M, Sharp DM, Tiffen JC, Ryan RM, Jormakka M, Haass NK, Rasko JE and Holst J. Targeting glutamine transport to suppress melanoma cell growth. Int J Cancer 2014; 135: 1060-71.
9. Wang Y, Liu Y, Shen X, Zhang X, Chen X, Yang C and Gao H. The PIWI protein acts as a predictive marker for human gastric cancer. Int J Clin Exp Pathol 2012; 5: 315-325.
10. Huang F, Nie C, Yang Y, Yue W, Ren Y, Shang Y, Wang X, Jin H, Xu C and Chen Q. Selenite induces redox-dependent Bax activation and apoptosis in colorectal cancer cells. Free Radic Biol Med 2009; 46: 1186-1196.
11. Witte D, Ali N, Carlson N and Younes M. Overexpression of the neutral amino acid transporter ASCT2 in human colorectal adenocarcinoma. Anticancer Res 2002; 22: 2555-2557.
12. Li R, Younes M, Frolov A, Wheeler TM, Scardino P, Ohori M and Ayala G. Expression of neutral amino acid transporter ASCT2 in human prostate. Anticancer Res 2003; 23: 3413-3418.
13. Palacin M, Estevez R, Bertran J and Zorzano A. Molecular biology of mammalian plasma membrane amino acid transporters. Physiol Rev 1998; 78: 969-1054.
14. Fuchs BC and Bode BP. Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Semin Cancer Biol 2005; 15: 254-266.
15. Shimizu K, Kaira K, Tomizawa Y, Sunaga N, Kawashima O, Oriuchi N, Tominaga H, Nagamori S, Kanai Y, Yamada M, Oyama T and Takeyoshi I. ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer. Br J Cancer 2014; 110: 2030-2039.
16. Younes M, Pathak M, Finnie D, Sifers RN, Liu Y and Schwartz MR. Expression of the neutral amino acids transporter ASCT1 in esophageal carcinomas. Anticancer Res 2000; 20: 3775-3779.
17. Kung HN, Marks JR and Chi JT. Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia. PLoS Genet 2011; 7: e1002229.
18. van den Heuvel AP, Jing J, Wooster RF and Bachman KE. Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth. Cancer Biol Ther 2012; 13: 1185-1194.
19. Duran RV, Oppliger W, Robitaille AM, Heiserich L, Skendaj R, Gottlieb E and Hall MN. Glutaminolysis activates Rag-mTORC1 signaling. Mol Cell 2012; 47: 349-358.
20. Nicklin P, Bergman P, Zhang B, Triantafellow E, Wang H, Nyfeler B, Yang H, Hild M, Kung C, Wilson C, Myer VE, MacKeigan JP, Porter JA, Wang YK, Cantley LC, Finan PM and Murphy LO. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 2009; 136: 521-534.
21. Pawlik TM, Souba WW, Sweeney TJ and Bode BP. Phorbol esters rapidly attenuate glutamine uptake and growth in human colon carcinoma cells. J Surg Res 2000; 90: 149-155.
22. Qu W, Zha Z, Ploessl K, Lieberman BP, Zhu L, Wise DR, Thompson CB and Kung HF. Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors. J Am Chem Soc 2011; 133: 1122-1133.
23. Lieberman BP, Ploessl K, Wang L, Qu W, Zha Z, Wise DR, Chodosh LA, Belka G, Thompson CB and Kung HF. PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine. J Nucl Med 2011; 52: 1947-1955.